Article Versions Notes

Narasimhan M, Mahimainathan L, Araj E, Clark AE, Wilkinson K, Yekkaluri S, Tiro J, Lee FM, Balani J, Sarode R, et al. Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST). Vaccines. 2021; 9(4):376. https://doi.org/10.3390/vaccines9040376

Narasimhan, Madhusudhanan, Lenin Mahimainathan, Ellen Araj, Andrew E Clark, Kathleen Wilkinson, Sruthi Yekkaluri, Jasmin Tiro, Francesca M Lee, Jyoti Balani, Ravi Sarode, and et al. 2021. "Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST)" Vaccines 9, no. 4: 376. https://doi.org/10.3390/vaccines9040376

Narasimhan, M., Mahimainathan, L., Araj, E., Clark, A. E., Wilkinson, K., Yekkaluri, S., Tiro, J., Lee, F. M., Balani, J., Sarode, R., Singal, A. G., & Muthukumar, A. (2021). Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST). Vaccines, 9(4), 376. https://doi.org/10.3390/vaccines9040376